Navigation Links
Weikang Bio-Technology Group Co., Inc. Announces Fiscal Year 2011 Financial Results
Date:4/2/2012

2011

Net sales

Net sales for the year ended December 31, 2011 were $101.68 million, compared to $74.55 million for the year ended December 31, 2010, an increase of $27.13 million or 36%.  Increase in units of products sold for the year ended December 31, 2011 accounted for approximately 75% of increase in sales primarily due to 1) the production and sales of new products starting in the third quarter of 2010, which brought us approximately $7.80 million sales revenue during the year of 2011; and 2) a six-month promotion plan starting from the fourth quarter of 2010 to the end of first quarter of 2011, which is the peak season for sales of health care products in the PRC due to the Chinese New Year Holiday and Chinese tradition of having tonic in winter. The remaining 25% increase in sales was attributable to the increase in unit sales price for certain highly demand products, such as Ferrous Fumarate Granule, Eucommia Ulmoides Oliv Granule, Tinidazole Vaginal Effervescent Tablet, Bushen Qiangshen Tablet, and Ranitidine Hydrochloride Capsule.

Gross profit

Gross profit was $59.59 million for the year ended December 31, 2011, compared to $45.02 million for the comparable period of 2010, our gross margin was 59% and 60% of sales for the year ended December 31, 2011 and 2010, respectively. The decrease in our gross profit margin for the year ended December 31, 2011 was mainly due to increase in cost of goods sold resulting from increase taxes for cost of goods sold.

Net income

Net income for the year ended December 31, 2011 was $29.63 million compared to $24.44 million for the same period of 2010, an increase of $5.19 million or 21%.  The increase was mainly attributable to increase in net sales.

Liquidity and Capital Resources

At December 31, 2011, the Company had cash and equivalents of $70.78 million, other current assets of $11.06 million, and current l
'/>"/>

SOURCE Weikang Bio-Technology Group Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Weikang Bio-technology Group, Inc. Completes HQ Relocation After Purchasing Building for $14 Million and Answers Questions About its Third Quarter Financials
2. Weikang Bio-Technology to Present at Rodman & Renshaw Annual China Investment Conference
3. Weikang Bio-Technology Announces Inclusion of Ranitidine Hydrochloride Capsule on National Drug Reimbursement List
4. Weikang Bio-Technology Expects to Report Fiscal 2010 Revenue of $77.8 Million and Net Income of $31.2 Million or $1.04 Earnings per Share
5. Weikang Bio-Technology Plans to Launch New Therapeutics in First Quarter 2011
6. Weikang Bio-Technology to Present at Global Hunter 2010 China Conference on July 13, 2010
7. Weikang Bio-Technology Announces Filing for NASDAQ Listing
8. Weikang Bio-Technology Reports First Quarter 2010 Financial Results
9. Optimer Pharmaceuticals, Inc. Announces Presentation at ECCMID of Post-Hoc Subgroup Analysis of DIFICID in Adult Cancer Patients Being Treated for Clostridium difficile-Associated Diarrhea (CDAD)
10. Huntzinger Management Group, Inc., (HMG) Further Invests in Healthcare Industrys "90 Percent"
11. Leading Financial Analyst Group Estimates 5-Year Revenue for HRID at $42MM
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & ... for shareholders detailing why a "YES" vote to increase the ... As we reflect upon the 2014 fiscal year ...
(Date:1/23/2015)... January 23, 2015 Heptares Therapeutics, the clinical-stage ... announce that the Malcolm Campbell Memorial Prize for ... President of Chemistry), Fiona Marshall (Chief Scientific Officer ... and co-founder) for the seminal contributions to GPCR drug discovery ...
(Date:1/22/2015)... DIEGO, Jan. 22, 2015  ResMed Inc. (NYSE: RMD ... 2014. Revenue for the quarter was $423.0 million, a 10 ... (a 14 percent increase on a constant currency basis). Net ... to the quarter ended December 31, 2013. Diluted earnings per ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... Nov. 7, 2011 Perrigo Company (Nasdaq: PRGO ... that Perrigo has begun shipping Levocetirizine Solution, 2.5 mg/5ml, a ... first to file ANDA application for the generic that entitle ... in this product was settled earlier this year. Perrigo is ...
... PTC Therapeutics, Inc. announced today ... Explorations, an initiative created by the Bill & ... test unorthodox ideas that address persistent health and ... will pursue an innovative global health research project, ...
Cached Medicine Technology:Perrigo and its Partner Synthon Launch Levocetirizine Solution - Generic Equivalent to Xyzal® Oral Solution 2Perrigo and its Partner Synthon Launch Levocetirizine Solution - Generic Equivalent to Xyzal® Oral Solution 3PTC Therapeutics Receives Grand Challenges Explorations Funding 2PTC Therapeutics Receives Grand Challenges Explorations Funding 3
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased ... Clinical Pharmacy Services at North Carolina State’s College of ... 2015 Beal Award for Distinguished Volunteer Service—the organization’s highest ... the contributions of volunteer experts to direct its work ...
(Date:1/22/2015)... 2015 LunaDress, with its top dressmaking technologies, ... Now, the business is showing its latest designs of wedding ... According to the company’s CEO, all the fresh new products ... big discounts, up to 80% off. All the clothes from ...
(Date:1/22/2015)... 2015 Woodloch Pines, an all-inclusive family ... by TripAdvisor as the number one best large hotel for ... the world for their annual Travelers’ Choice Awards. , ... The website is home to millions of unbiased and honest ...
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, AZ ... Alliance (PPHA). The PPHA's passion for others' well-being and ... greats, treated for obstructive sleep apnea (OSA) has propelled them ... in the valley. The most recent plans for an event ...
(Date:1/22/2015)... January 22, 2015 The Incredible Bulk is ... Pakulski to increase lean muscle by up to 30lbs in ... the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. ... is a step-by-step, scientific diet formula that allows the body ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2
... , , NEW YORK, Sept. ... is available in its catalogue. , , ... Critical Trends in a Fast-Changing Industry , ... The global market for human vaccines has experienced strong ...
... , NEW YORK, Sept. 22 ... is available in its catalogue. , , ... and Therapeutics: (MRSA, HAP, C. diff and other Hospital ... http://www.reportlinker.com/p099448/Nosocomial-Infections-Market-Impact-on-Diagnostics-and-Therapeutics-(MRSA-HAP-C-diff-and-other-Hospital-Acquired-Infections).html , ...
... , , WASHINGTON, Sept. 22 ... been competitively selected to present company profiles before potential investors ... to present was open to companies at all stages of ... leaders and stakeholders and those with the highest scores were ...
... Sept. 22 Reportlinker.com announces that a new market research ... Omega Fatty Acids: Trends in the Worldwide ... , http://www.reportlinker.com/p099455/Omega-Fatty-Acids-Trends-in-the-Worldwide-Food-and-Beverage-Markets-2nd-Edition.html , , ... phase in the global retail market. Since 2003, thousands of ...
... , , , , ... (the "Company"), a manufacturer and distributor of the EQ Smart Energy Drink(R) ... sales for the EQ product line in Mexico recently. , ... Group (ESP Group) of Ensenada, Mexico, the EQ Smart Energy Drink was ...
... WOODLAND HILLS, Calif., Sept. 22 Anthem Blue Cross, ... on Physical Fitness and Sports, is launching a 16-week traveling ... to make healthy lifestyle choices now and in the future. ... Release, go to: http://www.prnewswire.com/mnr/livelikeachampion/40152/ , ...
Cached Medicine News:Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 2Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 3Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 4Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 5Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 6Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 7Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 8Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 9Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 10Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 11Health News:Reportlinker Adds Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Report 12Health News:Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report 2Health News:Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report 3Health News:Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report 4Health News:Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report 5Health News:Reportlinker Adds Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections) Report 6Health News:Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders & Financiers at AdvaMed 2009 2Health News:Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders & Financiers at AdvaMed 2009 3Health News:Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders & Financiers at AdvaMed 2009 4Health News:Innovative Medical Technology Companies From Around the World Selected to Present Profiles to Industry Leaders & Financiers at AdvaMed 2009 5Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 2Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 3Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 4Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 5Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 6Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 7Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 8Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 9Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 10Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 11Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 12Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 13Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 14Health News:Reportlinker Adds Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition Report 15Health News:EQ Energy Drink Experiencing Substantial Sales Increases in Mexico 2
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes....
RNase-free Tips...
MBP's 200 ul large orifice tip is perfect for handling fragile cells, viscous samples and genomic....
... is an innovative, quick and easy ... Use 60% less space on your ... With this amazingly easy-to-use, one-hand system, ... the whole range of Diamond Tips. ...
Medicine Products: